Location History:
- Cupertino, CA (US) (2009 - 2016)
- Kirkland, WA (US) (2015 - 2016)
Company Filing History:
Years Active: 2009-2016
Title: **The Innovations of Philippe J M Dor**
Introduction
Philippe J M Dor, based in Cupertino, California, is a noted inventor with a remarkable portfolio of seven patents. His work primarily focuses on advancements in the field of therapeutic formulations, with a particular emphasis on the application of rapamycin in treating various eye conditions.
Latest Patents
Among his latest innovations, Dor has developed liquid rapamycin formulations aimed at treating or preventing diseases such as choroidal neovascularization and age-related macular degeneration (AMD). His patents detail methods for administering these formulations effectively, ensuring prolonged delivery of therapeutic agents through unique liquid carriers. Additionally, he has formulated liquid solutions capable of creating a non-dispersed mass in aqueous environments, allowing for innovative administration routes including intraocular or periocular delivery. These formulations underscore Dor’s commitment to improving treatment outcomes for patients suffering from serious retinal conditions.
Career Highlights
Philippe J M Dor's career has been marked by significant contributions to the pharmaceutical industry. He has collaborated with renowned organizations such as Santen Pharmaceutical Co., Ltd. and Macusight, Inc., demonstrating his ability to work within reputable companies to bring innovative treatments to market. His deep understanding of pharmaceutical sciences is evident in his patents that address unmet medical needs in ocular health.
Collaborations
Throughout his career, Dor has collaborated with notable professionals like Thierry Nivaggioli and Sreenivasu Mudumba. These partnerships have propelled the development of groundbreaking therapies, further establishing his reputation within the medical and pharmaceutical communities.
Conclusion
Philippe J M Dor exemplifies the spirit of innovation within the pharmaceutical industry. With his seven patents focused on advancing treatment methodologies using liquid rapamycin formulations, he continues to pave the way for new therapeutic possibilities in addressing critical eye health challenges. His dedication to research and collaboration positions him as a prominent figure in the field of medical inventions.